MINNEAPOLIS, April 21, 2014 /PRNewswire/ -- Techne Corporation (NASDAQ:TECH), d/b/a Bio-Techne, today announced that management will host a conference call on Monday, April 28, 2014, at 7:30 a.m. CDT to review third quarter fiscal 2014 financial results.
Access to the discussion may be obtained as follows:
Time: 7:30 a.m CDT
Date: April 28, 2014
A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by going to:
The replay will be available from 5:00 PM CDT on Monday, April 28, 2014 until 5:00 PM CDT on Monday, May 26, 2014.
Techne Corporation (d/b/a Bio-Techne) is engaged in the development, manufacture and sale of biotechnology products and clinical controls through its two operating subsidiaries: Research and Diagnostic Systems, Inc. (R&D Systems) of Minneapolis, Minnesota and R&D Systems Europe, Ltd. (R&D Europe) of Abingdon, England.
R&D Systems is a specialty manufacturer of biological products. R&D Systems has four subsidiaries: Bionostics, Inc., located in Devens, MA; BiosPacific, Inc. (BiosPacific), located in Emeryville, CA; Boston Biochem, Inc., located in Cambridge, MA; and R&D China, located in Shanghai, China. Bionostics develops, manufactures and supplies clinical controls primarily for point-of-care instrumentation on a worldwide basis. BiosPacific is a worldwide supplier of biologics to manufacturers of in vitro diagnostic systems and immunodiagnostic kits. Boston Biochem is a leading developer and manufacturer of ubiquitin-related research products.
R&D China and R&D Europe distribute our biotechnology division products. R&D Europe has two subsidiaries: Tocris Holdings Ltd. (Tocris) of Bristol, England and R&D Systems GmbH, a German sales operation. Tocris is a leading supplier of chemical reagents for non-clinical life science research.
SOURCE Techne Corporation